Helix Research Network (HRN)
Sponsor: Cone Health
A observational or N/A phase clinical study on Genetic Predisposition to Disease and Genetics Disease, this trial is actively recruiting participants. The trial is conducted by Cone Health and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Oct 2025 — Feb 2026 [monthly]
Recruiting
-
Apr 2025 — Oct 2025 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
-
May 2024 — Jun 2024 [monthly]
Recruiting
-
Dec 2023 — May 2024 [monthly]
Recruiting
-
Oct 2023 — Dec 2023 [monthly]
Recruiting
First recorded
Sep 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cone Health
- HealthPartners Institute
- Helix, Inc
- Medical University of South Carolina
- Memorial Hermann Health System
- Ohio State University
- Parkview Health
- Renown Health
- Rochester Regional Health
- Sanford Health
- St. Luke's Hospital and Health Network, Pennsylvania
- University Health Network, Toronto
- University of Nebraska
- WakeMed Health and Hospitals
- WellSpan Health
For direct contact, visit the study record on ClinicalTrials.gov .